Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death?
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Ferroptosis has emerged as a new type of cell death in different pathological conditions, including neurological and kidney diseases and, especially, in different types of cancer. The hallmark of this regulated cell death is the presence of iron-driven lipid peroxidation; the activation of key genes related to this process such as glutathione peroxidase-4 (gpx4), acyl-CoA synthetase long-chain family member-4 (acsl4), carbonyl reductase [NADPH] 3 (cbr3), and prostaglandin peroxidase synthase-2 (ptgs2); and morphological changes including shrunken and electron-dense mitochondria. Iron overload in the liver has long been recognized as both a major trigger of liver damage in different diseases, and it is also associated with liver fibrosis. New evidence suggests that ferroptosis might be a novel type of non-apoptotic cell death in several liver diseases including non-alcoholic steatohepatitis (NASH), alcoholic liver disease (ALD), drug-induced liver injury (DILI), viral hepatitis, and hemochromatosis. The interaction between iron-related lipid peroxidation, cellular stress signals, and antioxidant systems plays a pivotal role in the development of this novel type of cell death. In addition, integrated responses from lipidic mediators together with free iron from iron-containing enzymes are essential to understanding this process. The presence of ferroptosis and the exact mechanisms leading to this non-apoptotic type of cell death in the liver remain scarcely elucidated. Recognizing ferroptosis as a novel type of cell death in the liver could lead to the understanding of the complex interaction between different types of cell death, their role in progression of liver fibrosis, the development of new biomarkers, as well as the use of modulators of ferroptosis, allowing improved theranostic approaches in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · cited 1×
“The prevailing type of cell death is tissue, spatiotemporal, and situation-specific, and it seems to be a constitutive mechanism in the normal development and physiology of a tissue [19].”
BackgroundDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999 · cited 1×
“The result is the activation of multiple defense enzymatic systems, leading to cytoprotective processes aimed at preserving the integrity of the cell and its components [89,90].”
BackgroundInactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3722 · Cited by 3,219 · cited 2×
“This interaction takes place on the outer membrane of mitochondria and includes three different subgroups within the Bcl-2 family: BH3-only proteins (initiates apoptosis, includes Bid, Bim, and Puma), pro-survival elements (such as Bcl-2), and the effectors of apoptosis (Bax and Bak) [40].”
BackgroundPore-forming activity and structural autoinhibition of the gasdermin family
Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., Sun, H., Wang, D.-C., & Shao, F. (2016) · Nature · doi:10.1038/nature18590 · Cited by 2,771
Autophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583 · cited 2×
“Then, the autophagosome matures and sequesters completely the intracellular cargo (its outer membrane fusing with the lysosome), forming an autolysosome, where its inner membrane and content are degraded by the acid hydrolases [28,31,55].”
Background
Research works printed but not linked: 140
- Green, 2002, AGA technical review on the evaluation of liver chemistry tests, Gastroenterology, 123, 1367, 10.1053/gast.2002.36061 · DOI · Paper page
- Rinella, 2015, Nonalcoholic fatty liver disease: A systematic review, JAMA, 313, 2263, 10.1001/jama.2015.5370 · DOI · Paper page
- Moriyama, 2005, Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy, Liver Int., 25, 85, 10.1111/j.1478-3231.2005.01028.x · doi:10.1111/j.1478-3231.2005.01028.x
- Miyake, 2006, Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis, Aliment. Pharmacol. Ther., 24, 1197, 10.1111/j.1365-2036.2006.03113.x · DOI
- Eguchi, 2014, Biomarkers of liver cell death, J. Hepatol., 60, 1063, 10.1016/j.jhep.2013.12.026 · DOI · Paper page
- Luedde, 2014, Cell death and cell death responses in liver disease: Mechanisms and clinical relevance, Gastroenterology, 147, 765, 10.1053/j.gastro.2014.07.018 · DOI · Paper page
- Wang, 2015, Molecular mechanisms of hepatic apoptosis regulated by nuclear factors, Cell. Signal., 27, 729, 10.1016/j.cellsig.2014.11.038 · DOI
- Dixon, 2012, Ferroptosis: An iron-dependent form of nonapoptotic cell death, Cell, 149, 1060, 10.1016/j.cell.2012.03.042 · DOI · Paper page
- Mehta, 2019, Iron and liver fibrosis: Mechanistic and clinical aspects, World J. Gastroenterol., 25, 521, 10.3748/wjg.v25.i5.521 · DOI · Paper page
- Pietrangelo, 2009, Iron in NASH, chronic liver diseases and HCC: How much iron is too much?, J. Hepatol., 50, 249, 10.1016/j.jhep.2008.11.011 · DOI
- Li, 2015, The Role of Oxidative Stress and Antioxidants in Liver Diseases, Int. J. Mol. Sci., 16, 26087, 10.3390/ijms161125942 · DOI · Paper page
- Man, 2016, Converging roles of caspases in inflammasome activation, cell death and innate immunity, Nat. Rev. Immunol., 16, 7, 10.1038/nri.2015.7 · DOI · Paper page
- Hotchkiss, 2009, Cell Death, N. Engl. J. Med., 361, 1570, 10.1056/NEJMra0901217 · DOI · Paper page
- Rautou, 2008, Acute Liver Cell Damage in Patients With Anorexia Nervosa: A Possible Role of Starvation-Induced Hepatocyte Autophagy, Gastroenterology, 135, 840, 10.1053/j.gastro.2008.05.055 · DOI · Paper page
- Lamkanfi, 2016, Pyroptosis, Curr. Biol., 26, R568, 10.1016/j.cub.2016.02.019 · DOI · Paper page
- Wallach, 2016, Programmed necrosis in inflammation: Toward identification of the effector molecules, Science, 352, aaf2154, 10.1126/science.aaf2154 · DOI · Paper page
- Mizushima, 2011, Autophagy: Renovation of cells and tissues, Cell, 147, 728, 10.1016/j.cell.2011.10.026 · DOI · Paper page
- Ueno, 2017, Autophagy in the liver: Functions in health and disease, Nat. Rev. Gastroenterol. Hepatol., 14, 170, 10.1038/nrgastro.2016.185 · DOI · Paper page
- Cadwell, 2016, Crosstalk between autophagy and inflammatory signalling pathways: Balancing defence and homeostasis, Nat. Rev. Immunol., 16, 661, 10.1038/nri.2016.100 · DOI · Paper page
- Denton, 2019, Autophagy-dependent cell death, Cell Death Differ., 26, 605, 10.1038/s41418-018-0252-y · DOI · Paper page
- Guicciardi, 2005, Apoptosis: A mechanism of acute and chronic liver injury, Gut, 54, 1024, 10.1136/gut.2004.053850 · DOI · Paper page
- Wang, 2014, Molecular mechanisms of hepatic apoptosis, Cell Death Dis., 5, e996, 10.1038/cddis.2013.499 · DOI · Paper page
- Taylor, 2008, Apoptosis: Controlled demolition at the cellular level, Nat. Rev. Mol. Cell Biol., 9, 231, 10.1038/nrm2312 · DOI · Paper page
- Canbay, 2003, Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression, Hepatology, 38, 1188, 10.1053/jhep.2003.50472 · DOI · Paper page
- Green, 1998, Mitochondria and apoptosis, Science, 281, 1309, 10.1126/science.281.5381.1309 · DOI · Paper page
- Bao, 2007, Apoptosome: A platform for the activation of initiator caspases, Cell Death Differ., 14, 56, 10.1038/sj.cdd.4402028 · DOI · Paper page
- Ow, 2008, Cytochrome c: Functions beyond respiration, Nat. Rev. Mol. Cell Biol., 9, 532, 10.1038/nrm2434 · DOI · Paper page
- Wilson, 2009, Death receptor signal transducers: Nodes of coordination in immune signaling networks, Nat. Immunol., 10, 348, 10.1038/ni.1714 · DOI · Paper page
- Bordon, 2016, Cell death and immunity: Gasdermins: The hole picture emerges, Nat. Rev. Immunol., 16, 401, 10.1038/nri.2016.76 · doi:10.1038/nri.2016.76
- Thome, 1997, Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors, Nature, 386, 517, 10.1038/386517a0 · DOI · Paper page
- Galluzzi, 2017, Necroptosis: Mechanisms and Relevance to Disease, Annu. Rev. Pathol. Mech. Dis., 12, 103, 10.1146/annurev-pathol-052016-100247 · DOI · Paper page
- Krysko, 2008, Apoptosis and necrosis: Detection, discrimination and phagocytosis, Methods, 44, 205, 10.1016/j.ymeth.2007.12.001 · DOI · Paper page
- Tomaipitinca, L., Mandatori, S., Mancinelli, R., Giulitti, F., Petrungaro, S., Moresi, V., Facchiano, A., Ziparo, E., Gaudio, E., and Giampietri, C. (2019). The Role of Autophagy in Liver Epithelial Cells and Its Impact on Systemic Homeostasis. Nutrients, 11. · DOI
- Mizushima, 2008, Autophagy fights disease through cellular self-digestion, Nature, 451, 1069, 10.1038/nature06639 · DOI · Paper page
- Yang, 2007, Permeases recycle amino acids resulting from autophagy, Autophagy, 3, 149, 10.4161/auto.3631 · DOI
- Fleming, 2012, Iron overload in human disease, N. Engl. J. Med., 366, 348, 10.1056/NEJMra1004967 · DOI · Paper page
- Meynard, 2014, The liver: Conductor of systemic iron balance, Blood, 123, 168, 10.1182/blood-2013-06-427757 · DOI · Paper page
- Zhao, 2013, Iron regulation by hepcidin, J. Clin. Invest., 123, 2337, 10.1172/JCI67225 · DOI · Paper page
- Wang, 2019, Liver iron sensing and body iron homeostasis, Blood, 133, 18, 10.1182/blood-2018-06-815894 · DOI · Paper page
- Gaschler, 2017, Lipid peroxidation in cell death, Biochem. Biophys. Res. Commun., 482, 419, 10.1016/j.bbrc.2016.10.086 · DOI · Paper page
- Dalleau, 2013, Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance, Cell Death Differ., 20, 1615, 10.1038/cdd.2013.138 · DOI · Paper page
- Feng, H., and Stockwell, B.R. (2018). Unsolved mysteries: How does lipid peroxidation cause ferroptosis?. PLoS Biol., 16. · DOI · Paper page
- Shimada, 2016, Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity, Cell Chem. Biol., 23, 225, 10.1016/j.chembiol.2015.11.016 · DOI · Paper page
- Sato, 1999, Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins, J. Biol. Chem., 274, 11455, 10.1074/jbc.274.17.11455 · DOI · Paper page
- Xu, 2013, Iron and copper in mitochondrial diseases, Cell Metab., 17, 319, 10.1016/j.cmet.2013.02.004 · DOI · Paper page
- Beard, 2001, Iron Biology in Immune Function, Muscle Metabolism and Neuronal Functioning, J. Nutr., 131, 568S, 10.1093/jn/131.2.568S · DOI · Paper page
- Wang, 2017, Characterization of ferroptosis in murine models of hemochromatosis, Hepatology, 66, 449, 10.1002/hep.29117 · DOI · Paper page
- Lee, 2018, Ferroptosis-induced endoplasmic reticulum stress: Cross-talk between ferroptosis and apoptosis, Mol. Cancer Res., 16, 1073, 10.1158/1541-7786.MCR-18-0055 · DOI · Paper page
- Amri, 1994, Fatty acids as signal transducing molecules: Involvement in the differentiation of preadipose to adipose cells, J. Lipid Res., 35, 930, 10.1016/S0022-2275(20)39187-2 · DOI · Paper page
- De Carvalho, C.C.C.R., and Caramujo, M.J. (2018). The various roles of fatty acids. Molecules, 23. · DOI · Paper page
- Sellmayer, 1996, Effects of different polunsaturated fatty acids on growth-related early gene expression and cell growth, Lipids, 31, S37, 10.1007/BF02637048 · doi:10.1007/bf02637048
- Brash, 2001, Arachidonic acid as a bioactive molecule, J. Clin. Invest., 107, 1339, 10.1172/JCI13210 · DOI · Paper page
- Tang, 1996, Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis, Proc. Natl. Acad. Sci. USA., 93, 5241, 10.1073/pnas.93.11.5241 · DOI · Paper page
- Magtanong, 2016, Emerging roles for lipids in non-apoptotic cell death, Cell Death Differ., 23, 1099, 10.1038/cdd.2016.25 · DOI · Paper page
- Fullerton, 2014, Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2, Nat. Med., 20, 518, 10.1038/nm.3516 · DOI · Paper page
- McMahon, 2001, The Cap’n’Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes, Cancer Res., 61, 3299
- Leone, 2015, Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway, Free Radic. Biol. Med., 89, 287, 10.1016/j.freeradbiomed.2015.07.155 · DOI
- Kang, 2004, Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes, Proc. Natl. Acad. Sci. USA, 101, 2046, 10.1073/pnas.0308347100 · DOI · Paper page
- Long, 2017, β-TrCP1 Is a Vacillatory Regulator of Wnt Signaling, Cell Chem. Biol., 24, 944, 10.1016/j.chembiol.2017.06.009 · DOI
- Takaya, 2012, Validation of the multiple sensor mechanism of the Keap1-Nrf2 system, Free Radic. Biol. Med., 53, 817, 10.1016/j.freeradbiomed.2012.06.023 · DOI · Paper page
- Chiu, 2014, Special issue on “Oxidative stress and mitochondrial alterations in aging and disease”, Free Radic. Res., 48, 967, 10.3109/10715762.2014.948536 · DOI
- Kim, 2009, 15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: Possible roles of iron and ROS, Carcinogenesis, 30, 645, 10.1093/carcin/bgp012 · DOI
- Suzuki, 2018, An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment, Antioxid. Redox Signal., 29, 1746, 10.1089/ars.2017.7358 · DOI
- Kawatani, 2011, Nrf2 and selenoproteins are essential for maintaining oxidative homeostasis in erythrocytes and protecting against hemolytic anemia, Blood, 117, 986, 10.1182/blood-2010-05-285817 · DOI
- Liu, 2013, Pirin is an iron-dependent redox regulator of NF-κB, Proc. Natl. Acad. Sci. USA, 110, 9722, 10.1073/pnas.1221743110 · DOI · Paper page
- Nakajima, 2013, Bidirectional regulation of NF-κB by reactive oxygen species: A role of unfolded protein response, Free Radic. Biol. Med., 65, 162, 10.1016/j.freeradbiomed.2013.06.020 · DOI · Paper page
- Kalinowski, 2012, Nitrogen monoxide (NO) storage and transport by dinitrosyl-dithiol-iron complexes: Long-lived NO that is trafficked by interacting proteins, J. Biol. Chem., 287, 6960, 10.1074/jbc.R111.329847 · DOI
- Richardson, 2008, The nitric oxide-iron interplay in mammalian cells: Transport and storage of dinitrosyl iron complexes, Biochim. Biophys. Acta, 1780, 638, 10.1016/j.bbagen.2007.12.009 · DOI
- Ding, 2000, Direct nitric oxide signal transduction via nitrosylation of iron-sulfur centers in the SoxR transcription activator, Proc. Natl. Acad. Sci. USA, 97, 5146, 10.1073/pnas.97.10.5146 · DOI · Paper page
- Osler, 1899, Clinical Remarks on Hypertrophic Cirrhosis of the Liver with Bronzing of the Skin: Haemochromatosis, Br. Med. J., 2, 1595, 10.1136/bmj.2.2032.1595 · doi:10.1136/bmj.2.2032.1595
- Anderson, 2013, Iron homeostasis in the liver, Compr. Physiol., 3, 315, 10.1002/cphy.c120016 · DOI · Paper page
- Niederau, 1996, Long-term survival in patients with hereditary hemochromatosis, Gastroenterology, 110, 1107, 10.1053/gast.1996.v110.pm8613000 · DOI · Paper page
- Fracanzani, 1995, Portal hypertension and iron depletion in patients with genetic hemochromatosis, Hepatology, 22, 1127, 10.1002/hep.1840220417 · DOI
- Cooksey, 2004, Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis, Endocrinology, 145, 5305, 10.1210/en.2004-0392 · DOI · Paper page
- Castro, 2002, Blood letting in high-ferritin type 2 diabetes: Effects on insulin sensitivity and beta-cell function, Diabetes, 51, 1000, 10.2337/diabetes.51.4.1000 · DOI · Paper page
- Valenti, 2011, Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study, QJM, 104, 141, 10.1093/qjmed/hcq170 · DOI
- Simcox, 2013, Iron and diabetes risk, Cell Metab., 17, 329, 10.1016/j.cmet.2013.02.007 · DOI · Paper page
- Deugnier, 2017, Dysmetabolic iron overload syndrome (DIOS), Presse Med., 46, e306, 10.1016/j.lpm.2017.05.036 · DOI
- Turlin, 2001, Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients, Am. J. Clin. Pathol., 116, 263, 10.1309/WWNE-KW2C-4KTW-PTJ5 · DOI · Paper page
- Marmur, J., Beshara, S., Eggertsen, G., Onelöv, L., Albiin, N., Danielsson, O., Hultcrantz, R., and Stål, P. (2018). Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease. BMC Gastroenterol., 18. · DOI
- Kowdley, 2012, NASH Clinical Research Network Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease, Hepatology, 55, 77, 10.1002/hep.24706 · DOI · Paper page
- Valenti, 2010, HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease, Gastroenterology, 138, 905, 10.1053/j.gastro.2009.11.013 · DOI · Paper page
- Fracanzani, 2011, Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity, J. Hepatol., 54, 1244, 10.1016/j.jhep.2010.09.037 · DOI
- Fargion, 2001, Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis, Am. J. Gastroenterol., 96, 2448, 10.1111/j.1572-0241.2001.04052.x · doi:10.1111/j.1572-0241.2001.04052.x · Paper page
- Manousou, 2011, Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients, Liver Int., 31, 730, 10.1111/j.1478-3231.2011.02488.x · DOI · Paper page
- Hoki, 2015, Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis, Hepatology, 62, 751, 10.1002/hep.27774 · DOI
- Dongiovanni, 2011, Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target, J. Hepatol., 55, 920, 10.1016/j.jhep.2011.05.008 · DOI · Paper page
- Beaton, M.D., Chakrabarti, S., Levstik, M., Speechley, M., Marotta, P., and Adams, P. (2013). Phase II clinical trial of phlebotomy for non-Alcoholic fatty liver disease. Aliment. Pharmacol. Ther. · DOI
- Schafer, 2006, Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression, J. Biol. Chem., 281, 22974, 10.1074/jbc.M602098200 · DOI · Paper page
- Klein, 2007, Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol, Hepatology, 46, 1979, 10.1002/hep.21895 · DOI · Paper page
- Eng, 2005, V Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis, Liver Int., 25, 513, 10.1111/j.1478-3231.2005.01004.x · DOI
- Batista, 2012, Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls, Eur. J. Gastroenterol. Hepatol., 24, 1158, 10.1097/MEG.0b013e328355cfd0 · DOI
- Hultcrantz, 1993, Iron increases ethanol toxicity in rat liver, J. Hepatol., 17, 108, 10.1016/S0168-8278(05)80530-6 · DOI
- Tsukamoto, 1995, Experimental liver cirrhosis induced by alcohol and iron, J. Clin. Invest., 96, 620, 10.1172/JCI118077 · DOI · Paper page
- Fletcher, 2002, Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis, Gastroenterology, 122, 281, 10.1053/gast.2002.30992 · DOI · Paper page
- Pietrangelo, 2003, Iron-induced oxidant stress in alcoholic liver fibrogenesis, Alcohol, 30, 121, 10.1016/S0741-8329(03)00126-5 · DOI
- Raynard, 2002, Risk factors of fibrosis in alcohol-induced liver disease, Hepatology, 35, 635, 10.1053/jhep.2002.31782 · DOI · Paper page
- Christidis, 2000, Liver iron is predictive of death in alcoholic cirrhosis: A multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: A prospective follow up study, Gut, 46, 277, 10.1136/gut.46.2.277 · DOI · Paper page
- Ma, L., Zou, T., Yuan, Y., Lv, J., Dong, X., Yang, G., Zhu, Y., Luo, J., Zhang, Z., and Yang, J. (2014). Duodenal ferroportin is up-regulated in patients with chronic hepatitis C. PLoS One, 9. · DOI
- Fujita, 2007, Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients, Free Radic. Biol. Med., 42, 353, 10.1016/j.freeradbiomed.2006.11.001 · DOI
- Lambrecht, 2011, HALT-C Trial Group Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C, Gastroenterology, 140, 1490, 10.1053/j.gastro.2011.01.053 · DOI
- Guyader, 2007, Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C, J. Hepatol., 46, 587, 10.1016/j.jhep.2006.09.021 · DOI
- Martin, 2013, Identification of transferrin receptor 1 as a hepatitis C virus entry factor, Proc. Natl. Acad. Sci. USA, 110, 10777, 10.1073/pnas.1301764110 · doi:10.1073/pnas.1301764110
- Theurl, 2004, Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3, J. Infect. Dis., 190, 819, 10.1086/422261 · DOI · Paper page
- Li, 2016, Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications, J. Hepatol., 64, S32, 10.1016/j.jhep.2016.02.011 · DOI
- Ryan, 2012, Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C, Hepatology, 56, 492, 10.1002/hep.25666 · DOI · Paper page
- Ferrara, 2009, Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C, Am. J. Gastroenterol., 104, 605
- Lange, 2012, Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy, Hepatology, 55, 1038, 10.1002/hep.24787 · DOI
- Andrade, 2017, Drug-induced liver injury: Recent advances in diagnosis and risk assessment, Gut, 66, 1154, 10.1136/gutjnl-2016-313369 · DOI · Paper page
- Lee, 2017, Acetaminophen (APAP) hepatotoxicity-Isn’t it time for APAP to go away?, J. Hepatol., 67, 1324, 10.1016/j.jhep.2017.07.005 · DOI · Paper page
- Du, 2016, Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential, Redox Biol., 10, 148, 10.1016/j.redox.2016.10.001 · DOI · Paper page
- Heidari, 2016, Effect of Thiol-reducing Agents and Antioxidants on Sulfasalazine-induced Hepatic Injury in Normotermic Recirculating Isolated Perfused Rat Liver, Toxicol. Res., 32, 133, 10.5487/TR.2016.32.2.133 · DOI
- Ramappa, 2013, Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management, J. Clin. Exp. Hepatol., 3, 37, 10.1016/j.jceh.2012.12.001 · DOI · Paper page
- Laarakkers, 2012, Acute acetaminophen intoxication leads to hepatic iron loading by decreased hepcidin synthesis, Toxicol. Sci., 129, 225, 10.1093/toxsci/kfs176 · DOI
- Nahon, 2008, Liver Iron, HFE Gene Mutations, and Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis, Gastroenterology, 134, 102, 10.1053/j.gastro.2007.10.038 · DOI · Paper page
- Hellerbrand, 2003, HFE C282Y heterozygosity in hepatocellular carcinoma: Evidence for an increased prevalence, Clin. Gastroenterol. Hepatol., 1, 279, 10.1016/S1542-3565(03)00132-0 · DOI
- Louandre, 2013, Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib, Int. J. Cancer, 133, 1732, 10.1002/ijc.28159 · DOI · Paper page
- Lachaier, 2014, Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors, Anticancer Res., 34, 6417
- Okuma, 2018, Survival analysis and pathological features of advanced non-small cell lung cancer with miliary pulmonary metastases in patients harboring epidermal growth factor receptor mutations, J. Cancer Res. Clin. Oncol., 144, 1601, 10.1007/s00432-018-2681-x · DOI
- Raja, 1994, Intestinal iron absorption studies in mouse models of iron-overload, Br. J. Haematol., 86, 156, 10.1111/j.1365-2141.1994.tb03267.x · doi:10.1111/j.1365-2141.1994.tb03267.x
- Fleming, R.E., Feng, Q., and Britton, R.S. (2011). Knockout Mouse Models of Iron Homeostasis. Annu. Rev. Nutr. · DOI
- Masaratana, 2011, Iron absorption in hepcidin1 knockout mice, Br. J. Nutr., 105, 1583, 10.1017/S0007114510005507 · DOI
- Lunova, 2014, Hepcidin knockout mice fed with iron-rich diet develop chronic liver injury and liver fibrosis due to lysosomal iron overload, J. Hepatol., 61, 633, 10.1016/j.jhep.2014.04.034 · DOI
- Kalaitzakis, 2013, Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis, Scand. J. Gastroenterol., 48, 577, 10.3109/00365521.2013.777468 · DOI
- Les, 2010, Quality of life in cirrhosis is related to potentially treatable factors, Eur. J. Gastroenterol. Hepatol., 22, 221, 10.1097/MEG.0b013e3283319975 · DOI · Paper page
- Qamar, 2009, Incidence, Prevalence, and Clinical Significance of Abnormal Hematologic Indices in Compensated Cirrhosis, Clin. Gastroenterol. Hepatol., 7, 689, 10.1016/j.cgh.2009.02.021 · DOI · Paper page
- Cirera, 1997, Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension, Dig. Dis. Sci., 42, 1697, 10.1023/A:1018861415259 · DOI
- Zhang, 2019, Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model, Cell Chem. Biol., 26, 623, 10.1016/j.chembiol.2019.01.008 · DOI · Paper page
- Sato, 2018, The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells, Sci. Rep., 8, 1
- Sui, 2018, RSL3 drives ferroptosis through GPX4 inactivation and ros production in colorectal cancer, Front. Pharmacol., 9, 1371, 10.3389/fphar.2018.01371 · DOI · Paper page
- Bordin, 2019, Inactivation of the glutathione peroxidase GPx4 by the ferroptosis-inducing molecule RSL3 requires the adaptor protein 14-3-3ε, FEBS Lett., 594, 611
- Miotto, 2020, Insight into the mechanism of ferroptosis inhibition by ferrostatin-1, Redox Biol., 28, 101328, 10.1016/j.redox.2019.101328 · DOI · Paper page
- Liu, 2015, The 5-Lipoxygenase Inhibitor Zileuton Confers Neuroprotection against Glutamate Oxidative Damage by Inhibiting Ferroptosis, Biol. Pharm. Bull., 38, 1234, 10.1248/bpb.b15-00048 · DOI · Paper page
- Kajarabille, N., and Latunde-Dada, G.O. (2019). Latunde-Dada Programmed Cell-Death by Ferroptosis: Antioxidants as Mitigators. Int. J. Mol. Sci., 20. · DOI · Paper page
- Kagan, 2017, Oxidized Arachidonic/Adrenic Phosphatidylethanolamines Navigate Cells to Ferroptosis, Nat. Chem. Biol., 13, 81, 10.1038/nchembio.2238 · DOI · Paper page
- Silva, 2004, Reevaluating the role of 1,10-phenanthroline in oxidative reactions involving ferrous ions and DNA damage, Biochim. Biophys. Acta - Gen. Subj., 1675, 46, 10.1016/j.bbagen.2004.08.006 · DOI
- Viganor, 2016, The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance, Curr. Top. Med. Chem., 17, 1280, 10.2174/1568026616666161003143333 · DOI
- Taher, 2016, Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes, Drug Des. Devel. Ther., 10, 4073, 10.2147/DDDT.S117080 · doi:10.2147/dddt.s117080
- Kontoghiorghes, 2019, Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology, Expert Opin. Investig. Drugs, 28, 593, 10.1080/13543784.2019.1631284 · DOI
- Hider, 2018, The role of deferiprone in iron chelation, N. Engl. J. Med., 379, 2140, 10.1056/NEJMra1800219 · DOI
Cited by
Ferroptosis in Liver Diseases: An Overview
Capelletti, M. M., Manceau, H., Puy, H., & Peoc’h, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144908 · Cited by 361
Lin, F., Chen, W., Zhou, J., Zhu, J., Yao, Q., Feng, B., Feng, X., Shi, X., Pan, Q., Yu, J., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04708-w · Cited by 206
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
Segovia-Zafra, A., Di Zeo-Sánchez, D. E., López-Gómez, C., Pérez-Valdés, Z., García-Fuentes, E., Andrade, R. J., Lucena, M. I., & Villanueva-Paz, M. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.013 · Cited by 70
The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress
Kholodenko, I. V., Kholodenko, R. V., & Yarygin, K. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015212 · Cited by 16
Metadata
- Authors
- Macías-Rodríguez, R. U., Inzaugarat, M. E., Ruiz-Margáin, A., Nelson, L. J., Trautwein, C., & Cubero, F. J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-02-28
- Volume
- 21
- Issue
- 5
- Pages
- 1651
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3009904103
- Cited by
- 115
- References
- 48
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death? https://app.cochat.ai/papers/10.3390/ijms21051651
- The paper
- Macías-Rodríguez, R. U., Inzaugarat, M. E., Ruiz-Margáin, A., Nelson, L. J., Trautwein, C., & Cubero, F. J. (2020). Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death? International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21051651
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.